Congress 116 - HR 4100 - DISARM Act of 2019

Sponsor

Cosponsors

Topics

Congressional oversight Drug safety, medical device, and laboratory regulation Government information and archives Government studies and investigations Health Infectious and parasitic diseases Medicare

Full Text

View Full Bill Text

Votes

Summary

Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019

This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.

Actions

Jul 31, 2019

Referred to the Subcommittee on Health.
Jul 30, 2019

Referred to the Subcommittee on Health.
Jul 30, 2019

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 30, 2019

Introduced in House

Amendments

Related Bills